SE400076B - Forfarande for framstellning av 5-(3-substituerade amino-2-hydroxipropoxi)-1,3-disubstituerade pyrazolforeningar vilka uppvisar beta-adrenergiskt blockerande egenskaper - Google Patents
Forfarande for framstellning av 5-(3-substituerade amino-2-hydroxipropoxi)-1,3-disubstituerade pyrazolforeningar vilka uppvisar beta-adrenergiskt blockerande egenskaperInfo
- Publication number
- SE400076B SE400076B SE7305383A SE7305383A SE400076B SE 400076 B SE400076 B SE 400076B SE 7305383 A SE7305383 A SE 7305383A SE 7305383 A SE7305383 A SE 7305383A SE 400076 B SE400076 B SE 400076B
- Authority
- SE
- Sweden
- Prior art keywords
- proproxy
- hydroxy
- procedure
- preparation
- substituted amino
- Prior art date
Links
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical class C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 title 1
- 230000000903 blocking effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
- C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/28—Two oxygen or sulfur atoms
- C07D231/30—Two oxygen or sulfur atoms attached in positions 3 and 5
- C07D231/32—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA141470A CA1001161A (en) | 1972-05-05 | 1972-05-05 | 5-(3-substituted amino-2-hydroxypropoxy)1,3-disubstituted pyrazoles and method of preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE400076B true SE400076B (sv) | 1978-03-13 |
Family
ID=4093188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7305383A SE400076B (sv) | 1972-05-05 | 1973-04-16 | Forfarande for framstellning av 5-(3-substituerade amino-2-hydroxipropoxi)-1,3-disubstituerade pyrazolforeningar vilka uppvisar beta-adrenergiskt blockerande egenskaper |
Country Status (14)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2619164C2 (de) * | 1976-04-30 | 1985-07-11 | Boehringer Mannheim Gmbh, 6800 Mannheim | Indazolyl-(4)-oxy-propanolamine, Verfahren zu ihrer Herstellung und deren Verwendung |
| FI57617C (fi) * | 1979-01-18 | 1980-09-10 | Viljanmaa Antti | Spaennanordning foer skinn |
| DE2926517A1 (de) * | 1979-06-30 | 1981-01-15 | Beiersdorf Ag | Substituierte 3-aryl-pyrazole und 5-aryl-isoxazole und verfahren zu ihrer herstellung |
| US5547967A (en) * | 1993-12-08 | 1996-08-20 | Kali-Chemie Pharma Gmbh | (Phenylalkylaminoalkyloxy)-heteroaryl-compounds, processes and intermediates for their production and pharmaceutical compositions containing them |
| DE4341749A1 (de) * | 1993-12-08 | 1995-06-14 | Kali Chemie Pharma Gmbh | 3-(Phenylalkylaminoalkyloxy)-5-phenylpyrazol- Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| CO5011072A1 (es) * | 1997-12-05 | 2001-02-28 | Lilly Co Eli | Etanolaminas pirazinil substituidas como agfonistas de los receptores |
| EP1036064A4 (en) * | 1997-12-05 | 2002-11-27 | Lilly Co Eli | SELECTIVE BETA 3-ADRENERGIC ANTAGONISTS |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1201061A (en) * | 1966-08-26 | 1970-08-05 | Endo Lab | Oxo pyrroles and process for preparing same |
| US3629433A (en) * | 1968-09-16 | 1971-12-21 | Ciba Geigy Corp | Antidepressant compositions of cycloalkano(c)pyrazole ethers |
| US3637738A (en) * | 1969-02-12 | 1972-01-25 | Ciba Geigy Corp | Cycloalkano(c)pyrazole ethers |
| US3726896A (en) * | 1970-05-06 | 1973-04-10 | Szabo Hnos Kessler & Cia | 1-benzyl-3(2,3-dihydroxypropoxy)indazole |
-
1972
- 1972-05-05 CA CA141470A patent/CA1001161A/en not_active Expired
-
1973
- 1973-04-16 SE SE7305383A patent/SE400076B/xx unknown
- 1973-04-18 NL NL7305477A patent/NL7305477A/xx not_active Application Discontinuation
- 1973-04-27 AU AU54937/73A patent/AU474793B2/en not_active Expired
- 1973-04-30 GB GB2047573A patent/GB1390485A/en not_active Expired
- 1973-05-01 JP JP48047644A patent/JPS4947367A/ja active Pending
- 1973-05-03 ES ES414320A patent/ES414320A1/es not_active Expired
- 1973-05-03 DE DE2322313A patent/DE2322313A1/de not_active Ceased
- 1973-05-03 FR FR7315861A patent/FR2183751B1/fr not_active Expired
- 1973-05-04 ZA ZA733049A patent/ZA733049B/xx unknown
- 1973-05-04 HU HUME1624A patent/HU165583B/hu unknown
- 1973-05-04 CH CH636973A patent/CH582677A5/xx not_active IP Right Cessation
- 1973-05-04 BE BE130745A patent/BE799098A/xx unknown
-
1974
- 1974-11-06 US US521416A patent/US3920691A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU474793B2 (en) | 1976-08-05 |
| ES414320A1 (es) | 1976-02-01 |
| ZA733049B (en) | 1974-12-24 |
| CH582677A5 (US07902200-20110308-C00004.png) | 1976-12-15 |
| NL7305477A (US07902200-20110308-C00004.png) | 1973-11-07 |
| BE799098A (fr) | 1973-11-05 |
| GB1390485A (en) | 1975-04-16 |
| FR2183751B1 (US07902200-20110308-C00004.png) | 1976-10-22 |
| JPS4947367A (US07902200-20110308-C00004.png) | 1974-05-08 |
| AU5493773A (en) | 1974-10-31 |
| FR2183751A1 (US07902200-20110308-C00004.png) | 1973-12-21 |
| HU165583B (US07902200-20110308-C00004.png) | 1974-09-28 |
| DE2322313A1 (de) | 1973-11-22 |
| US3920691A (en) | 1975-11-18 |
| CA1001161A (en) | 1976-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE7506819L (sv) | Forfarande for framstellning av substituerade 1,2,4-triazolderivat | |
| SE382459B (sv) | Forfarande for framstellning av xantonderivat. | |
| DK133672B (da) | Analogifremgangsmåde til fremstilling af imidazolderivater. | |
| NO138532C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-(4-fenoksy-fenyl)-1,3,5-triazin-derivater | |
| FI55194B (fi) | Foerfarande foer framstaellning av 6-substituerade 4-amino-1,2-dihydro-1-hydroxi-2-iminopyrimidiner | |
| SE381047B (sv) | Forfarande for framstellning av 3-substituerade 1,2-bensisoxazolderivat | |
| AR206214A1 (es) | Procedimiento para la preparacion de nuevos compuestos derrivados de 1-(4-substituido)-fenoxi-2-hidroxi-3-amino propano | |
| SE400076B (sv) | Forfarande for framstellning av 5-(3-substituerade amino-2-hydroxipropoxi)-1,3-disubstituerade pyrazolforeningar vilka uppvisar beta-adrenergiskt blockerande egenskaper | |
| NO156086C (no) | Analogifremgangsmaate for fremstilling av substituerte heterocykliske fenoksyaminer. | |
| IT974512B (it) | Procedimento per la preparazione di composti immino eterociclici | |
| SE7608958L (sv) | Forfarande for framstellning av 2-(fenoxialkyl-sulfinyl eller -sulfonyl) imidazoler | |
| SE398120B (sv) | Forfarande for framstellning av 3-(1-piperazinylalkyl)-2,4-kinazolindionforeningar | |
| SE408709B (sv) | Forfarande for framstellning av indol-, resp azaindol merkatoforeningar | |
| SE416201B (sv) | Foerfarande foer framstaellning av 1,4-bensodiazepinderivat | |
| SE397085B (sv) | Forfarande for framstellning av 2-(6'-karbalkoxihexyl)-4(r)-hydroxicyklopentan-1,3-dioner | |
| NO142669C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive, heterocykliske forbindelser | |
| SE410458B (sv) | Forfarande for framstellning av vissa angivna 1,2,4-triazolderivat | |
| SE387940B (sv) | Forfarande for framstellning av stereoisomerer av 1-(1-(-kloorbensyl)-2'-pyrryl)-2-disek, butylaminoetanol | |
| DK135042B (da) | Analogifremgangsmåde til fremstilling af 3,5-disubstituerede triazolderivater. | |
| DK127297B (da) | Analogifremgangsmåde til fremstilling af heterocyclisk substituerede nebularinderivater. | |
| AR219897A1 (es) | Procedimiento para la preparacion de 1-sustituido, 5-(fenil) sustituido)-3-metil-1,3,5-triazapenta-1,4-dieno | |
| SE408302B (sv) | Forfarande for framstellning av 1,4-bensodiazepin-derivat | |
| SE384506B (sv) | Analogiforfarande for framstellning av 1-(polyfluoralkyl)-1,4-bensodiazepin-2-tioner | |
| DK426576A (da) | Fremgangsmade til fremstilling af 1-alkyl-3,5-disubstituerede 1,2,4-triazolderivater | |
| DK132409C (da) | Fremgangsmade til fremstilling af heterocyclisk substitueredemalonatestere |